Fortuno , Maraviroc was developed by Pfizer , because it is CCR5 inhibitor , use in HIV CCR5 positive patients , is that why you connecting Maraviroc and Gilead ?? as a treatment for HIV ?

Now they doing studies with Maraviroc and cancers ....

To my knowledge right now Gilead is not working with CCR5 and cancers or HIV.
But generally they looking to develop new ways of treatment for both diseases ...

I know they have special interest in CAR-T cell therapy for cancer , also developing Capcid inhibitors for HIV...

But I agree they may have an interest with Leronlimab for both HIV and cancers .... ( having choice , because of side effects they will not choose Maraviroc )
and I believe that CYDY will like that...this will not be a problem..

Actually I am surprise , why not for so long ?????

All IMO.